11. THE RESULT OF TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA IN THE EMERGENCY DEPARTMENT, VIETNAM NATIONAL CHILDREN'S HOSPITAL
Main Article Content
Abstract
Objective: To evaluate the results of emergency treatment of supraventricular tachycardia in
children according to the APLS 2021 protocol at the Emergency Department - National Children’s
Hospital. Subjects and research methods: Children who were diagnosed with supraventricular
tachyarrhythmias when admitted to the Emergency - Anti-toxicity Department of the National
Children’s Hospital. Results: Children over one year old accounted for the majority (76%). There
are 46 cases of successful cessation, accounting for 92%. Treating supraventricular tachycardia is
mainly used with drugs (accounting for 90), in which adenosine is primarily used (96%). There were
76.6% cases of successful cessation with adenosine and the highest rate of successful termination of
the second dose, accounting for 57.7%. The rate of successful cessation in the group of children under
one year old and over one year old did not have a statistically significant difference (p>0.05). The
rate of acute heart failure decreased compared to before cessation with a difference with statistical
significance p < 0.05. Conclusion: Adenosine is an effective, safe, first-choice drug in managing
supraventricular tachycardia in children.
Article Details
Keywords
Treatment results, supraventricular tachycardia, National Children’s Hospital.
References
al., “Postnatal cumulative incidence of
supraventricular tachycardia in a general pediatric
population: A national birth cohort database
study”, Heart Rhythm, 2016; 13(10), 2070-5.
[2] Martial MM, Avram B, Gilles R, “Epidemiology
and outcome of tachyarrhythmias in tertiary
pediatric cardiac centers”, Cardiology, 2008;
111(3), 191-6.
[3] Chiu SN, Lu CW, Chang CW et al.,
Radiofrequency catheter ablation of
supraventricular tachyarrhythmia in infants and
toddlers. Circulation Journal. 2009, 73(9):1717-
1721.
[4] Jonathan L, Gaurav A, Dana LT et al., “Acute
Management of Refractory and Unstable
Pediatric Supraventricular Tachycardia”, Journal
of Pediatrics, 2017; 181, 177-182.
[5] Patrick VV, Nigel MT, Jana D et al., European
Resuscitation Council Guidelines 2021:
Paediatric Life Support. Resuscitation, 2021; 161
(2021), 327-387.
[6] Hội Tim mạch học Việt Nam, Khuyến cáo 2010
của Hội Tim mạch học Việt Nam về chẩn đoán
và điều trị một số rối loạn nhịp tim thường gặp.
Nhà xuất bản Y học, chi nhánh TP Hồ Chí Minh;
2010; tr. 195 – 205.
[7] Hoàng Văn Toàn, Đặng Thị Hải Vân, Nguyễn
Thanh Hải, Đặc điểm lâm sàng, cận lâm sàng cơn
tim nhanh ở trẻ em tại Bệnh viện Nhi trung ương.
Tạp chí Nhi khoa, 14 (1), tr. 43-49, 2021.
[8] Li M, Xiaomei L, Haiyan GE et al., “Effectiveness
of adenosine triphosphate on emergency
cardioversion of children with paroxysmal
supraventricular tachycardia”, Chinese Journal of
N.A. Vinh et al. / Vietnam Journal of Community Medicine, Vol 64, No 1 (2023) 79-8686
Practical Pediatrics; 2021; 36(13), 990 -994.
[9] Amanda Q, Janet L,Andrew D et al., “Age makes a
difference: Symptoms in pediatric upraventricular
tachycardia”, Journal of Arrhythmia, 2018, 34(5),
565-571.
[10] Bùi Gio An, Võ Công Đồng, “Đặc điểm chẩn
đoán và điều trị cấp cứu rối loạn nhịp nhanh ở
trẻ em nhập khoa cấp cứu Bệnh viện Nhi đồng
2”, Tạp chí Y học thành phố Hồ Chí Minh; 2009;
1(13), tr. 114-120.
[11] Sandra Díaz-Parra, Pilar Sánchez-Yañez, Ignacio
Zabala-Argüelles et al., Use of adenosine in the
treatment of supraventricular tachycardia in a
pediatric emergency department. Pediatr Emerg
Care, 2014; 30(6), 388-93.
[12] Henning C, “Pediatric arrhythmias in the
emergency department”, Emerg Med. 29, pp.
732- 737, 2012.